drugset / Trial / NCT01283412

Dexmedetomidine on Postoperative Delirium and Quality of Recovery in Geriatric Patients

NCT01283412

Phase 3 Unknown 500 enrolled Huazhong University of Science and Technology
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Postoperative agitation (hyperactive delirium) is common following major surgery(incidence was about 20% in our pilot study). Dexmedetomidine was related to a reduced delirium rate when comparing with midazolam in many clinical settings. It is not clear if dexmedetomidine is useful on reducing postoperative delirium. The hypothesis of present study: intraoperative application of dexmedetomidine (0.2ug/kg/h) is is effective (50% reduce) than placebo for reducing of early postoperative delirium and increase postoperative quality of recovery within 24 postoperative hours.

Timeline

Start
2013-06
Primary completion
2014-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous

Indications